Show Me Listing

Online Ebooks (PDF) Library

• Home
• Popular
• Latest
• Contact

Home » Industries » Pharmaceutical Industry

PHARMACEUTICAL INDUSTRY ALERT

Source: www.sidley.com
Topic: Pharmaceutical Industry

Sort Desciption: Pharmaceutical Industry Alert via. email, please send your name, ... Pharmaceutical Industry Alert. has been. prepared by Sidley Austin Brown & Wood ...

Content Inside: To receive future copies of the Pharmaceutical Industry Alert via email, please send your name, company or firm name and email address to jyeh@sidley.com PHARMACEUTICAL INDUSTRY ALERT The Pharmaceutical / Health Care Practice of Sidley Austin Brown & Wood LLP Our Pharmaceutical Industry/Health Care Practice represents participants in all facets of the health care industry, including pharmaceutical companies, pharmacies, manufacturers of dietary supplements, and medical device companies. Our lawyers combine a strong background in the complexities of health care financing and delivery,including coding,reimbursement, and coverage issues, privacy and security, trade regulation,and competition. We have extensive experience representing drug and device manufacturers on enforcement and regulatory matters before the Food and Drug Administration, the Centers for Medicare and Medicaid Services, the Office of the Inspector General for the Department of Health and Human Services, Federal Trade Commission, and state enforcement agencies. For further information on the Practice,please contact: Paul E. Kalb 202.736.8050 pkalb@sidley.com Jim C. Dechene 312.853.7275 jdechene@sidley.com Bill Sarraille 202.736.8195 wsarraille@sidley.com New Amendment to Maine Drug Price Reporting Requirement Revises CEO Certification Requirement; Additional Maine Disclosure Law Passed The State of Maine recently amended 22 Me.Rev.Stat.§ 2698-B,the Maine statute requiring pharmaceutical manufacturer’s to make quarterly disclosures of pricing information to the State (Drug Price Reporting Law). In a separate action, Maine also passed a law related to (1) clinical trials conducted or sponsored by pharmaceutical manufacturers, and (2) pharmaceutical manufacturer advertisements. Amendment to Drug Price Reporting Law The Drug Price Reporting Law currently requires manufacturers to report certain pricing information to the State,and further requires the manufacturer’s president ...

©2007 Show Me Listing - Designed by Free CSS Templates

RSS Feed Sitemap Privacy Policy